Skip Navigation

European Journal of Heart Failure 2005 7(6):1003-1010; doi:10.1016/j.ejheart.2004.11.001
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Petersson, M.
Right arrow Articles by Rundqvist, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petersson, M.
Right arrow Articles by Rundqvist, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society of Cardiology

Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure{star}

Magnus Peterssona,*, Peter Fribergb, Gavin Lambertc and Bengt Rundqvista

a Department of Cardiology, The Cardiovascular Institute, Sahlgrenska University Hospital S-413 45 Göteborg, Sweden
b Department of Clinical Physiology, Sahlgrenska University Hospital Göteborg, Sweden
c Baker Medical Research Institute Prahran, Australia

* Corresponding author. Tel.: +46 31 3424222; fax: +46 31 827614. E-mail address: magnus.petersson{at}wlab.gu.se


   Abstract

Aims: To examine changes in renal sympathetic outflow in response to cardiac unloading with nitroglycerin (GTN) in patients with chronic heart failure (CHF) and healthy subjects (HS).

Methods and Results: Renal (RNAsp) and total body (TBNAsp) noradrenaline (NA) spillover were measured with radiotracer methods in 16 patients with CHF (50±3 years, LVEF 20±1%) and nine HS (57±2 years) during right heart and renal vein catheterisation. Low dose GTN decreased mean pulmonary artery pressure (PAm: CHF –7±2 mm Hg, HS –4±1 mm Hg, p<0.05 vs. baseline) but not mean arterial pressure (MAP: CHF –2±1 mm Hg, HS –2±1 mm Hg) and did not affect RNAsp in any of the study groups. High dose GTN lowered MAP (CHF –12±1 mm Hg, HS –12±2 mm Hg, p<0.05 vs. baseline) and PAm (CHF –13±2 mm Hg, HS –5±1 mm Hg, p<0.05 vs. baseline) and was accompanied by a significant reduction in RNAsp only in CHF (1.3±0.1 nmol/min baseline to 0.9±0.2 nmol/min, p<0.05), whereas RNAsp in HS remained unchanged.

Conclusions: In spite of a reduction in both arterial pressure and cardiac filling pressures, renal sympathetic activity decreased in CHF and did not increase in HS. These findings suggest that the altered loading conditions resulting from high-dose GTN infusion have renal sympathoinhibitory effects.

Key Words: Heart failure • Congestive • Sympathetic nervous system • Renal circulation • Cardiovascular physiology • Baroreflex

Received July 30, 2004; Revised September 16, 2004; Accepted November 11, 2004


{star} This study was supported by grants from the Swedish Heart Lung Foundation, The Sahlgrenska Academy at Göteborg University and Göteborg Medical Society. No conflict of interest exists.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. S. Floras
Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.
J. Am. Coll. Cardiol., July 28, 2009; 54(5): 375 - 385.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.